26 views 0 likes

StayCurrentMD

GCMD Space · View profile →

Social Determinants of Health Influence on Survival in Wilms Tumor, Neuroblastoma, and Hepatoblastoma

Video Published 2026-01-09 Updated 2026-08-01

Timestops (3)

Here's a tough question we don't talk about enough in pediat…

Here's a tough question we don't talk about enough in pediatric oncology. How much does a child's social factors influen…

Then they made a socioeconomic Economic disadvantage score f…

Then they made a socioeconomic Economic disadvantage score for each patient based on the median household income and edu…

So what does this matter?

So what does this matter? Pediatric oncology outcomes aren't just about tumor biology or treatment received. It's about …

Topic Overview

A single-speaker presentation of a Cincinnati Children's retrospective study examining how socioeconomic disadvantage affects survival in three pediatric solid tumors. Analysis of 12,000 patients from the National Cancer Database found that children from the most disadvantaged communities had significantly worse survival for Wilms tumor and neuroblastoma, even after adjusting for clinical variables. The presenter argues that pediatric oncology outcomes depend not only on tumor biology and treatment but also on social determinants of health.

Key Takeaways

Socioeconomic disadvantage independently predicts worse survival in Wilms tumor (HR 2.02) and neuroblastoma after clinical adjustment. (0:31)
Study of 12,000 pediatric solid tumor patients used composite score of local income and education to quantify disadvantage. (0:12)
Social determinants affect outcomes even when controlling for tumor size, grade, treatment, and comorbidities. (0:37)
Identifying socioeconomic risk factors is essential to closing equity gaps in pediatric oncology survival. (1:00)

Inside this episode

Kai, the Library's AI content creator, listened to this episode and mapped who's speaking, the chapters, key claims, and cases. Every item links to the exact moment in the recording.

AI-enriched

Who's speaking

Sophia Schermerhorn — host

Chapters

0:00Social Determinants and Pediatric Oncology Survival — Introduction of a Cincinnati Children's study on socioeconomic disadvantage and survival in Wilms tumor, neuroblastoma, and hepatoblastoma, with presentation of key findings and clinical implications.

Key claims

0:12Study was a retrospective analysis of 12,000 patients with neuroblastoma, Wilms tumor, and hepatoblastoma from the National Cancer Database — Sophia Schermerhorn
0:20Socioeconomic disadvantage score was created for each patient based on median household income and education level in their local communities — Sophia Schermerhorn
0:31The most disadvantaged children were more likely to have worse survival for Wilms tumor and neuroblastoma — Sophia Schermerhorn
0:37After adjusting for tumor size, grade, treatment, and comorbidities, socioeconomic effects on survival remained present — Sophia Schermerhorn
0:44Hazard ratio for socioeconomic disadvantage was 2.02 for Wilms tumor — Sophia Schermerhorn
0:44Hazard ratio for socioeconomic disadvantage was 1.29 for hepatoblastoma — Sophia Schermerhorn
0:51Pediatric oncology outcomes depend on tumor biology, treatment received, and social determinants of health — Sophia Schermerhorn
1:00Identifying socioeconomic risk factors is necessary to close equity gaps and improve survival for all children with solid tumors — Sophia Schermerhorn

Open questions

What specific mechanisms link socioeconomic disadvantage to worse survival in these pediatric cancers?
What interventions can effectively address socioeconomic disparities in pediatric oncology outcomes?

This episode was analyzed and enriched by Kai, the Library's AI content creator. Every item links to the moment it comes from — click a timestamp to listen in context.

Socioeconomic Disadvantage Doubles Mortality Risk in Wilms Tumor Despite Standard Treatment

The essential version of this episode — what it covers, the points that matter most, and what it changes for you. Written by Kai from the episode transcript and reviewed before publishing.

For specialists · Core brief · AI-written, human-reviewed

Study Design and Population

A retrospective analysis of 12,000 patients with neuroblastoma, Wilms tumor, and hepatoblastoma from the National Cancer Database quantified the independent effect of socioeconomic disadvantage on survival 0:12. Investigators constructed a composite disadvantage score from median household income and education level in each patient's community 0:20.

Survival Disparities

Children in the most disadvantaged quartile demonstrated worse survival in Wilms tumor and neuroblastoma 0:31. The effect persisted after adjustment for tumor size, grade, treatment received, and comorbidities 0:37. For Wilms tumor, the hazard ratio was 2.02 — socioeconomically disadvantaged children faced double the mortality risk 0:44. Hepatoblastoma showed a more modest effect with a hazard ratio of 1.29 0:44.

Clinical Implications

The persistence of survival disparities after controlling for tumor characteristics and treatment delivery indicates that socioeconomic factors operate through mechanisms beyond delayed diagnosis or differential access to protocol therapy 0:37. The magnitude of effect in Wilms tumor — where cooperative group trials have achieved high overall survival — is particularly striking. A twofold increase in mortality risk among disadvantaged children suggests that factors such as treatment adherence, supportive care resources, or unmeasured social stressors may substantially modify outcomes even in highly curable malignancies.

The differential impact across tumor types (HR 2.02 for Wilms versus 1.29 for hepatoblastoma) raises questions about which aspects of treatment are most vulnerable to socioeconomic disruption 0:44 0:44. Wilms tumor protocols involve prolonged chemotherapy with strict adherence requirements; hepatoblastoma treatment is more surgery-centric with shorter chemotherapy courses.

What This Changes

Identifying socioeconomic risk factors represents a necessary step toward closing equity gaps in pediatric solid tumor survival 1:00. For clinicians managing these patients, the data argue for systematic screening of social determinants and proactive intervention — transportation assistance, care coordination, financial navigation — particularly in Wilms tumor and neuroblastoma where the survival penalty is most pronounced.

Takeaways from this story

Socioeconomic disadvantage doubles mortality risk in Wilms tumor (HR 2.02) even after adjusting for tumor and treatment factors.
Survival disparities persist independent of tumor size, grade, treatment received, and comorbidities in Wilms and neuroblastoma.
Hepatoblastoma shows smaller socioeconomic effect (HR 1.29), suggesting treatment structure may modify social vulnerability.
Composite disadvantage scores from income and education data can identify high-risk patients requiring social intervention.

Keywords

neuroblastoma Wilms tumor hepatoblastoma pediatric solid tumors Cincinnati Children's

Hashtags

#PediatricOncology #SocialDeterminants #Neuroblastoma #WilmsTumor #Hepatoblastoma #SurvivalRates #HealthcareEquity #CancerResearch #PatientOutcomes #Comorbidities #EconomicDisadvantage #HealthDisparities #TumorBiology #RiskFactors #CincinnatiChildrens #NationalCancerDatabase #EquityInHealth #ChildHealth #OncologyResearch #HealthEquity #SocialDeterminantsOfHealth

Transcript

Comments

Loading comments…